217 related articles for article (PubMed ID: 3052245)
1. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
2. [Cell kinetics of human meningiomas and neurinomas--Ki-67 PAP stain].
Shibata T; Burger PC; Kleihues P
No Shinkei Geka; 1988 Jul; 16(8):939-44. PubMed ID: 3050583
[TBL] [Abstract][Full Text] [Related]
3. [KI-67 PAP stain for histologic grading of brain tumors by squash preparations].
Shibata T; Ostertag CB; Volk B
No To Shinkei; 1989 Jan; 41(1):55-60. PubMed ID: 2470401
[TBL] [Abstract][Full Text] [Related]
4. Use of proliferative markers Ki-67 (MIB-1) and proliferating cell nuclear antigen (PC10) in transitional cell carcinoma of the renal pelvis.
Cheville JC; Terrell RB; Cohen MB
Mod Pathol; 1994 Sep; 7(7):794-800. PubMed ID: 7824516
[TBL] [Abstract][Full Text] [Related]
5. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
Torp SH; Lindboe CF; Granli US; Moen TM; Nordtømme T
Clin Neuropathol; 2001; 20(5):190-5. PubMed ID: 11594503
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical assessment of proliferative activity in adrenocortical neoplasms.
Goldblum JR; Shannon R; Kaldjian EP; Thiny M; Davenport R; Thompson N; Lloyd RV
Mod Pathol; 1993 Nov; 6(6):663-8. PubMed ID: 7508113
[TBL] [Abstract][Full Text] [Related]
8. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
[TBL] [Abstract][Full Text] [Related]
9. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
10. PCNA/cyclin expression in transitional cell carcinomas of the human bladder: its correlation with Ki-67 and epidermal growth factor receptor immunostainings.
Serio G
Pathologica; 1994 Apr; 86(2):161-6. PubMed ID: 7936759
[TBL] [Abstract][Full Text] [Related]
11. [Cell kinetics of oligodendroglioma and oligo-astrocytoma--Ki-67 PaP study].
Shibata T; Burger PC; Kleihues P
No To Shinkei; 1988 Aug; 40(8):779-85. PubMed ID: 3052541
[TBL] [Abstract][Full Text] [Related]
12. Ki-67 immunoreactivity in meningiomas--determination of the proliferative potential of meningiomas using the monoclonal antibody Ki-67.
Madsen C; Schrøder HD
Clin Neuropathol; 1997; 16(3):137-42. PubMed ID: 9197938
[TBL] [Abstract][Full Text] [Related]
13. MIB-1 staining index and peritumoral brain edema of meningiomas.
Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
Cancer; 1996 Jul; 78(1):133-43. PubMed ID: 8646709
[TBL] [Abstract][Full Text] [Related]
14. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
15. Cell proliferation correlates with prognosis in acinic cell carcinomas of salivary gland origin. Immunohistochemical study of 30 cases using the MIB 1 antibody in formalin-fixed paraffin sections.
Skalova A; Leivo I; Von Boguslawsky K; Saksela E
J Pathol; 1994 May; 173(1):13-21. PubMed ID: 7931834
[TBL] [Abstract][Full Text] [Related]
16. Proliferation markers Ki-67 and p105 in soft-tissue lesions. Correlation with DNA flow cytometric characteristics.
Swanson SA; Brooks JJ
Am J Pathol; 1990 Dec; 137(6):1491-500. PubMed ID: 1979714
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical evaluation of proliferative activity in human brain tumours.
Girino M; Riccardi A; Danova M; Gaetani P; Butti G; Giordano M; Cuomo A
Anal Cell Pathol; 1990 Sep; 2(5):269-75. PubMed ID: 2275874
[TBL] [Abstract][Full Text] [Related]
18. Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas.
Haapasalo J; Mennander A; Helen P; Haapasalo H; Isola J
J Clin Pathol; 2005 Mar; 58(3):263-8. PubMed ID: 15735157
[TBL] [Abstract][Full Text] [Related]
19. [In situ determination of the Ki-67 growth fraction (Ki-67 GF) in human tumors (studies in breast cancer)].
Lellé RJ
Acta Histochem Suppl; 1990; 39():109-24. PubMed ID: 2080254
[TBL] [Abstract][Full Text] [Related]
20. [Cellular kinetics of cerebral glioma: study of the proliferative activity using monoclonal antibody Ki 67. Apropos of 60 cases].
Parent M; Blond S; Gosset P; Lejeune JP; Lesoin F; Dhellemmes P; Jomin M; Christiaens JL; Dupont A
Arch Anat Cytol Pathol; 1990; 38(3):81-5. PubMed ID: 2363592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]